What changed
$MET — Manages life, accident, and health insurance globally.
🎯 Q1 FY26 | Rev $19B | EPS $2.42 vs $2.27 🟢
💡 Consensus expected EPS of $2.27; actual $2.42 (6.6% beat). The beat was largely from variable investment income (+58% YoY), which is volatile and not recurring. The market may be pricing in sustained momentum, but core operating trends (premium growth ~3%, operating cash flow down 37% YoY) suggest the beat is not a new run-rate.
🏢 Business Quality: 7/10 | Valuation: fair
📉 Reward/Risk: Upside 5-8% (to $90-93 on sustained momentum) vs downside 10-15% (to $73-77 on mean reversion in investment income). Ratio ~0.5x, unfavorable.
🔮 Catalyst: No near-term catalyst. Next earnings (Q2 2026, late July) will test whether variable investment income sustains. Key metric: adjusted ROE (currently ~12%). Failure signal: operating cash flow continues to decline.
Also in play: $X $TWTR $SNAP $PINS $META $GOOGL